OrthoPediatrics Corp. Investor Presentation April 2026

OrthoPediatrics Corp. presented their investor outlook for April 2026, highlighting their unique position as the only company exclusively focused on pediatric orthopedics. They emphasized their broad, specialized product portfolio, innovative solutions, and commitment to clinical education in the pediatric orthopedic field. The company detailed their strategic pillars, including a focus on high-volume children's hospitals, expanding their product offerings through R&D and M&A, and providing unparalleled sales support and training. They noted a growing addressable market, with a total global market of $6.2 billion and a U.S. addressable market of $2.8 billion. The presentation included financial highlights such as consistent year-over-year revenue growth, with a projected 2026 revenue between $263.0 and $267.0 million, and a focus on achieving free cash flow breakeven. OrthoPediatrics also outlined their market expansion strategies, particularly in specialty bracing, and provided guidance for 2026, anticipating continued growth and profitability.